98 related articles for article (PubMed ID: 22537621)
21. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
Cremona M; Calabrò E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
[TBL] [Abstract][Full Text] [Related]
22. [Screening of differentially expressed serum proteins in patients with asbestosis].
Ju L; Chen JQ; Jiang ZQ; Xiao Y; Zhu LJ; Jia ZY; Zhang X
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Jun; 30(6):408-12. PubMed ID: 22931765
[TBL] [Abstract][Full Text] [Related]
23. [Lung cancer in a female non-smoker with occupational exposure to asbestos: a case report].
Mazzetti L; Murer B; Quintavalle S; Zeni E; Miotto D; Mapp CE; De Rosa E; Boschetto P
Med Lav; 2006; 97(4):581-5. PubMed ID: 17017384
[TBL] [Abstract][Full Text] [Related]
24. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study.
Harris JM; Johnston ID; Rudd R; Taylor AJ; Cullinan P
Thorax; 2010 Jan; 65(1):70-6. PubMed ID: 19996344
[TBL] [Abstract][Full Text] [Related]
25. Exposure-response relationship between chrysotile exposure and mortality from lung cancer and asbestosis.
Deng Q; Wang X; Wang M; Lan Y
Occup Environ Med; 2012 Feb; 69(2):81-6. PubMed ID: 21742741
[TBL] [Abstract][Full Text] [Related]
26. Molecular and genetic changes in asbestos-related lung cancer.
Nymark P; Wikman H; Hienonen-Kempas T; Anttila S
Cancer Lett; 2008 Jun; 265(1):1-15. PubMed ID: 18364247
[TBL] [Abstract][Full Text] [Related]
27. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.
Sung HJ; Ahn JM; Yoon YH; Rhim TY; Park CS; Park JY; Lee SY; Kim JW; Cho JY
J Proteome Res; 2011 Mar; 10(3):1383-95. PubMed ID: 21141971
[TBL] [Abstract][Full Text] [Related]
29. Asbestos-related lung disease.
O'Reilly KM; Mclaughlin AM; Beckett WS; Sime PJ
Am Fam Physician; 2007 Mar; 75(5):683-8. PubMed ID: 17375514
[TBL] [Abstract][Full Text] [Related]
30. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
31. [Occupation and lung cancer risk in the province of Trieste: a case-control study].
Bovenzi M; Stanta G; Antiga GL; Peruzzo P; Cavallieri F
Med Lav; 1992; 83(4):338-48. PubMed ID: 1334212
[TBL] [Abstract][Full Text] [Related]
32. [Exposure to asbestos and levels of selected tumor biomarkers].
Krajewska B; Lutz W; Piłacik B
Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
[TBL] [Abstract][Full Text] [Related]
33. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis.
Stücker I; Boffetta P; Antilla S; Benhamou S; Hirvonen A; London S; Taioli E
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1253-8. PubMed ID: 11751442
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
Wu CC; Peng PH; Chang YT; Huang YS; Chang KP; Hao SP; Tsang NM; Yeh CT; Chang YS; Yu JS
Proteomics; 2008 Sep; 8(17):3605-20. PubMed ID: 18668694
[TBL] [Abstract][Full Text] [Related]
35. Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases.
Roggli VL; Sanders LL
Ann Occup Hyg; 2000 Mar; 44(2):109-17. PubMed ID: 10717262
[TBL] [Abstract][Full Text] [Related]
36. [Respiratory malignancies induced by asbestos exposure and evaluation of cases with typical pleural malignant mesothelioma and lung cancer with asbestosis].
Kishimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1078-84. PubMed ID: 2243458
[TBL] [Abstract][Full Text] [Related]
37. [Asbestos-related diseases observed in Palermo (Italy) among workers exposed to asbestos].
Costantino C; Amodio E; Costagliola E; Curcurù L; Ilardo S; Trapani E; Calamusa G
Ig Sanita Pubbl; 2011; 67(4):455-66. PubMed ID: 22033203
[TBL] [Abstract][Full Text] [Related]
38. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
39. Global DNA hypomethylation has no impact on lung function or serum inflammatory and fibrosis cytokines in asbestos-exposed population.
Yu M; Lou J; Xia H; Zhang M; Zhang Y; Chen J; Zhang X; Ying S; Zhu L; Liu L; Jia G
Int Arch Occup Environ Health; 2017 Apr; 90(3):265-274. PubMed ID: 28105512
[TBL] [Abstract][Full Text] [Related]
40. A simple high performance liquid chromatography method for quantitatively determining the reduced form of peroxiredoxin 2 and the mass spectrometric analysis of its oxidative status.
Ogasawara Y; Ishida Y; Takikawa M; Funaki Y; Suzuki T; Koike S
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():136-41. PubMed ID: 26113455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
